BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22102614)

  • 1. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
    Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
    Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
    Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
    Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
    Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
    Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.
    Wielders E; Delzenne-Goette E; Dekker R; van der Valk M; Te Riele H
    Fam Cancer; 2017 Apr; 16(2):221-229. PubMed ID: 27873144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
    Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
    Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic one.
    Kantelinen J; Hansen TV; Kansikas M; Krogh LN; Korhonen MK; Ollila S; Nyström M; Gerdes AM; Kariola R
    Fam Cancer; 2011 Sep; 10(3):515-20. PubMed ID: 21431882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
    Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
    Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage.
    Loconte DC; Patruno M; Lastella P; Di Gregorio C; Grossi V; Forte G; Ingravallo G; Varvara D; Bagnulo R; Simone C; Resta N; Stella A
    Hum Pathol; 2014 Oct; 45(10):2162-7. PubMed ID: 25106712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
    Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of pathogenicity in human MSH2 missense mutants.
    Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
    Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A database to support the interpretation of human mismatch repair gene variants.
    Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
    Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
    Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
    J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants.
    Kansikas M; Kariola R; Nyström M
    Hum Mutat; 2011 Jan; 32(1):107-15. PubMed ID: 21120944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.
    Rath A; Mishra A; Ferreira VD; Hu C; Omerza G; Kelly K; Hesse A; Reddi HV; Grady JP; Heinen CD
    Hum Mutat; 2019 Nov; 40(11):2044-2056. PubMed ID: 31237724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new variant database for mismatch repair genes associated with Lynch syndrome.
    Woods MO; Williams P; Careen A; Edwards L; Bartlett S; McLaughlin JR; Younghusband HB
    Hum Mutat; 2007 Jul; 28(7):669-73. PubMed ID: 17347989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity.
    Houlleberghs H; Goverde A; Lusseveld J; Dekker M; Bruno MJ; Menko FH; Mensenkamp AR; Spaander MCW; Wagner A; Hofstra RMW; Te Riele H
    PLoS Genet; 2017 May; 13(5):e1006765. PubMed ID: 28531214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological assessment of mismatch repair gene variants in Lynch syndrome: past, present, and future.
    Rasmussen LJ; Heinen CD; Royer-Pokora B; Drost M; Tavtigian S; Hofstra RM; de Wind N
    Hum Mutat; 2012 Dec; 33(12):1617-25. PubMed ID: 22833534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal.
    Pinto C; Pinheiro M; Peixoto A; Santos C; Veiga I; Rocha P; Pinto P; Lopes P; Baptista M; Henrique R; Teixeira MR
    J Hum Genet; 2016 Feb; 61(2):151-6. PubMed ID: 26446363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.